[go: up one dir, main page]

GB202105933D0 - Anti-IL1rap antibody - Google Patents

Anti-IL1rap antibody

Info

Publication number
GB202105933D0
GB202105933D0 GBGB2105933.2A GB202105933A GB202105933D0 GB 202105933 D0 GB202105933 D0 GB 202105933D0 GB 202105933 A GB202105933 A GB 202105933A GB 202105933 D0 GB202105933 D0 GB 202105933D0
Authority
GB
United Kingdom
Prior art keywords
il1rap antibody
il1rap
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2105933.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantargia AB
Original Assignee
Cantargia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantargia AB filed Critical Cantargia AB
Priority to GBGB2105933.2A priority Critical patent/GB202105933D0/en
Publication of GB202105933D0 publication Critical patent/GB202105933D0/en
Priority to EP21844985.8A priority patent/EP4267625A1/en
Priority to CA3202942A priority patent/CA3202942A1/en
Priority to JP2023538679A priority patent/JP2024500920A/en
Priority to AU2021405730A priority patent/AU2021405730A1/en
Priority to KR1020237020863A priority patent/KR20230123962A/en
Priority to IL303922A priority patent/IL303922A/en
Priority to MX2023007611A priority patent/MX2023007611A/en
Priority to CN202180085996.9A priority patent/CN116724055A/en
Priority to US17/559,227 priority patent/US11479610B2/en
Priority to PCT/EP2021/087338 priority patent/WO2022136569A1/en
Priority to US17/836,457 priority patent/US12043666B2/en
Ceased legal-status Critical Current

Links

GBGB2105933.2A 2020-12-23 2021-04-26 Anti-IL1rap antibody Ceased GB202105933D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2105933.2A GB202105933D0 (en) 2021-04-26 2021-04-26 Anti-IL1rap antibody
PCT/EP2021/087338 WO2022136569A1 (en) 2020-12-23 2021-12-22 Anti-il1rap antibody
AU2021405730A AU2021405730A1 (en) 2020-12-23 2021-12-22 Anti-il1rap antibody
CA3202942A CA3202942A1 (en) 2020-12-23 2021-12-22 Anti-il1rap antibody
JP2023538679A JP2024500920A (en) 2020-12-23 2021-12-22 Anti-IL1RAP antibody
EP21844985.8A EP4267625A1 (en) 2020-12-23 2021-12-22 Anti-il1rap antibody
KR1020237020863A KR20230123962A (en) 2020-12-23 2021-12-22 Anti-IL1RAP antibody
IL303922A IL303922A (en) 2020-12-23 2021-12-22 Anti-IL1RAP antibody
MX2023007611A MX2023007611A (en) 2020-12-23 2021-12-22 Anti-il1rap antibody.
CN202180085996.9A CN116724055A (en) 2020-12-23 2021-12-22 anti-IL1RAP antibody
US17/559,227 US11479610B2 (en) 2020-12-23 2021-12-22 Anti-IL1RAP antibody
US17/836,457 US12043666B2 (en) 2020-12-23 2022-06-09 Anti-IL1RAP antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2105933.2A GB202105933D0 (en) 2021-04-26 2021-04-26 Anti-IL1rap antibody

Publications (1)

Publication Number Publication Date
GB202105933D0 true GB202105933D0 (en) 2021-06-09

Family

ID=76193401

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2105933.2A Ceased GB202105933D0 (en) 2020-12-23 2021-04-26 Anti-IL1rap antibody

Country Status (2)

Country Link
CN (1) CN116724055A (en)
GB (1) GB202105933D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025201513A1 (en) * 2024-03-29 2025-10-02 珠海丹序生物制药有限公司 Anti-il1rap antibody and use thereof
CN120775049A (en) * 2024-04-03 2025-10-14 中山康方生物医药有限公司 Anti-IL-1 RAP antibodies, pharmaceutical compositions and uses thereof

Also Published As

Publication number Publication date
CN116724055A (en) 2023-09-08

Similar Documents

Publication Publication Date Title
SMT202300397T1 (en) Antibodies against sars-cov-2
IL308741A (en) Anti-sirp-alpha antibodies
PT4214240T (en) Anti-ccr8 antibodies
GB202105110D0 (en) Anti-CD73 antibodies
ZA202108836B (en) Anti-epha4 antibody
GB202111905D0 (en) Antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202015115D0 (en) ZIP12 Antibody
GB202105933D0 (en) Anti-IL1rap antibody
SG11201913540VA (en) Anti-Podoplanin Antibody
GB202309981D0 (en) Antibody
IL308782A (en) Antibodies
IL308100A (en) Antibodies
GB202102227D0 (en) Antibodies
GB201919062D0 (en) Antibody
GB202106027D0 (en) Antibody
GB202014969D0 (en) ZIP12 antibody
GB202208773D0 (en) Anti-SARS2-S antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
GB202115824D0 (en) Antibodies
GB202112297D0 (en) Antibodies
GB202107517D0 (en) Antibodies
GB202104128D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)